Hepatic expansion of virus-specific CD8+BTLA+ T cells with regulatory properties in chronic hepatitis B virus infection

Cellular Immunology

Volumn 311, Issue , 2017, Pages 36-45

  Wang, Huaizhou ^a,b   Wu, Beiying ^a   Li, Lei ^a   Hu, Liang ^a   Lin, Jiafei ^a   Jiang, Cen ^a   Cai, Gang ^a   Shen, Qian ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

B and T lymphocyte attenuator; Chronic virus infection; Hepatitis B virus; Regulatory CD8+ T cells

Indexed keywords

B AND LYMPHOCYTE ATTENUATOR; CD27 ANTIGEN; CD45RA ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA A24 ANTIGEN; INTERLEUKIN 10; PROGRAMMED DEATH 1 RECEPTOR; TETRAMER; UNCLASSIFIED DRUG; VIRUS DNA; BTLA PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MIDDLE AGED; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; ANTAGONISTS AND INHIBITORS; CELL CULTURE; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; YOUNG ADULT;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-10; LIVER; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 85002061897     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2016.10.002     Document Type: Article

References (35)

1. [1] Rehermann, B., Nascimbeni, M., Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5 (2005), 215–229.
2. [2] Bertoletti, A., Ferrari, C., Kinetics of the immune response during HBV and HCV infection. Hepatology 38 (2003), 4–13.
3. [3] Wherry, E.J., T cell exhaustion. Nat. Immunol. 12 (2011), 492–499.
4. [4] Chang, J.J., Thompson, A.J., Visvanathan, K., et al. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 46 (2007), 1332–1340.
5. [5] Zhang, Z., Zhang, J.Y., Wherry, E.J., et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134 (2008), 1938–1949 1949, e1-3.
6. [6] Boni, C., Fisicaro, P., Valdatta, C., et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81 (2007), 4215–4225.
7. [7] Nebbia, G., Peppa, D., Schurich, A., et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One, 7, 2012, e47648.
8. [8] Miroux, C., Vausselin, T., Delhem, N., Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immuneresponse. Expert Opin. Biol. Ther. 10 (2010), 1563–1572.
9. [9] Shevach, E.M., CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2 (2002), 389–400.
10. [10] Accapezzato, D., Francavilla, V., Paroli, M., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113 (2004), 963–972.
11. [11] Veiga-Parga, T., Sehrawat, S., Rouse, B.T., Role of regulatory T cells during virus infection. Immunol. Rev. 255 (2013), 182–196.
12. [12] Aalaei-Andabili, S.H., Alavian, S.M., Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis. Vaccine 30 (2012), 5595–5602.
13. [13] Youngblood, B., Noto, A., Porichis, F., et al. Cutting edge: prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells. J. Immunol. 191 (2013), 540–544.
14. [14] Hong, J.J., Amancha, P.K., Rogers, K., et al. Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection. PLoS One, 8, 2013, e60186.
15. [15] Desmet, V.J., Gerber, M., Hoofnagle, J.H., et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994), 1513–1520.
16. [16] Fisicaro, P., Valdatta, C., Massari, M., et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138 (2010), 682–693 693, e1–4.
17. [17] Cai, G., Nie, X., Li, L., et al. B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function. J. Gastroenterol. 48 (2013), 1362–1372.
18. [18] Serriari, N.E., Gondois-Rey, F., Guillaume, Y., et al. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 185 (2010), 3140–3148.
19. [19] Yuan, B., Zhao, L., Fu, F., et al. A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis. Mol. Immunol. 57 (2013), 93–99.
20. [20] Cai, G., Wang, H., Qin, Q., et al. Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells. Cardiovasc. Res. 84 (2009), 425–433.
21. [21] Maloy, K.J., Powrie, F., Regulatory T cells in the control of immune pathology. Nat. Immunol. 2 (2001), 816–822.
22. [22] Sakaguchi, S., Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101 (2000), 455–458.
23. [23] Shui, J.W., Steinberg, M.W., Kronenberg, M., Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling. J. Leukoc. Biol. 89 (2011), 517–523.
24. [24] Murphy, T.L., Murphy, K.M., Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu. Rev. Immunol. 28 (2010), 389–411.
25. [25] Boettler, T., Panther, E., Bengsch, B., et al. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J. Virol. 80 (2006), 3532–3540.
26. [26] Wherry, E.J., Teichgräber, V., Becker, T.C., et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4 (2003), 225–234.
27. [27] Gett, A.V., Sallusto, F., Lanzavecchia, A., et al. T cell fitness determined by signal strength. Nat. Immunol. 4 (2003), 355–360.
28. [28] Fourcade, J., Sun, Z., Pagliano, O., et al. CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res. 72 (2012), 887–896.
29. [29] Peretz, Y., He, Z., Shi, Y., et al. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog., 8, 2012, e1002840.
30. [30] Larrubia, J.R., Benito-Martínez, S., Miquel, J., et al. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(−) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection. Cell. Immunol. 269 (2011), 104–114.
31. [31] Franceschini, D., Paroli, M., Francavilla, V., et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119 (2009), 551–564.
32. [32] Milazzo, L., Ebranati, E., Cattaneo, D., et al. Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count. J. Med. Virol. 86 (2014), 97–101.
33. [33] Locarnini, S., Zoulim, F., Molecular genetics of HBV infection. Antivir. Ther. 15:Suppl. 3 (2010), 3–14.
34. [34] Wu, J., Meng, Z., Jiang, M., et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49 (2009), 1132–1140.
35. [35] Wei, C., Ni, C., Song, T., et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 185 (2010), 1158–1168.